Nanobiotix Financial Statements From 2010 to 2026
| NBTX Stock | USD 23.12 1.45 6.69% |
Check Nanobiotix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanobiotix's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nanobiotix financial statements analysis is a perfect complement when working with Nanobiotix Valuation or Volatility modules.
Nanobiotix | Build AI portfolio with Nanobiotix Stock |
Nanobiotix Company Return On Equity Analysis
Nanobiotix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nanobiotix Return On Equity | -1.99 |
Most of Nanobiotix's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanobiotix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nanobiotix has a Return On Equity of -1.9869. This is 91.71% lower than that of the Biotechnology sector and 94.55% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Nanobiotix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanobiotix's current stock value. Our valuation model uses many indicators to compare Nanobiotix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanobiotix competition to find correlations between indicators driving Nanobiotix's intrinsic value. More Info.Nanobiotix is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nanobiotix's earnings, one of the primary drivers of an investment's value.About Nanobiotix Financial Statements
Nanobiotix investors use historical fundamental indicators, such as Nanobiotix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nanobiotix. Please read more on our technical analysis and fundamental analysis pages.
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. The company was incorporated in 2003 and is headquartered in Paris, France. Nanobiotix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 103 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Nanobiotix Stock Analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.